Genotypic and Phenotypic Features of BAP1 Cancer Syndrome
Author(s) -
Alexandra M. Haugh,
Ching-Ni Jenny Njauw,
Jeffrey A. Bubley,
Anna Elisa Verzì,
Bin Zhang,
Emily Kudalkar,
Timothy VandenBoom,
Kara E. Walton,
Brian L. Swick,
Raj Kumar,
Huma Q. Rana,
Sarah Cochrane,
Shelley R. McCormick,
Christopher R. Shea,
Hensin Tsao,
Pedram Gerami
Publication year - 2017
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2017.2330
Subject(s) - medicine , germline mutation , bap1 , genotype , family history , genetic testing , germline , mutation , dermatology , cancer , oncology , genetics , gene , biology
Patients with germline mutations in BAP1 may develop several flesh-colored melanocytic BAP1-mutated atypical intradermal tumors (MBAITs). These tumors generally develop earlier than other BAP1-associated tumors, highlighting an important role for dermatologists in identifying and screening patients with a history suggestive of a germline mutation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom